Rationale and design of a randomised phase II multicentre crossover trial investigating a sodium-glucose co-transporter 2 inhibitor, dapagliflozin, combined with a novel continuous ketone monitor in adults with type 1 diabetes to reduce the risk of diabetic ketoacidosis: the PARTNER study
PARTNER 研究:一项随机 II 期多中心交叉试验的原理和设计,旨在研究钠-葡萄糖协同转运蛋白 2 抑制剂达格列净联合新型连续酮体监测仪在 1 型糖尿病成人患者中降低糖尿病酮症酸中毒风险的疗效。
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2024-098457
Ngan, Jennifer; Kong, Yee Wen; Goad, Jenna; Huang, Michael L H; Jenkins, Alicia; Vogrin, Sara; Trawley, Steven; Manzoney, Adele; Nakano, Miyuki; Ekinci, Elif; Kriketos, Adamandia; Fourlanos, Spiros; Boisseau, Lynelle; Nolan, Christopher J; Taylor, Pamela; Fenn, Joanne; Stranks, Stephen N; O'Neal, David Norman